Managing anti‐epileptic drug treatment in adult patients with intellectual disability: a serious conundrum
- 23 April 2016
- journal article
- review article
- Published by Wiley in European Journal of Neurology
- Vol. 23 (7), 1152-1157
- https://doi.org/10.1111/ene.13016
Abstract
About a quarter of people with epilepsy have intellectual disability (ID). This group has communication issues, premature mortality, more treatment resistance, difficulties in making informed choices and greater risks of physical and mental health comorbidities. There is no specific prescribing guidance for this large and vulnerable group. The literature on prescribing for epilepsy in this group was reviewed, in particular examining how antiepileptic drugs (AEDs) work regarding their side effect profiles, effects on specific epilepsy syndromes associated with ID and their individual strengths and weaknesses based on the nature and degree of ID.This is a narrative review for which a comprehensive search was conducted to identify evidence for prescribing commonly used AEDs to people with ID including genetic syndromes specifically associated with epilepsy.A detailed analysis of the results has highlighted the urgent requirement for suitable and reliable evidence in AED prescribing amongst adults with epilepsy and ID as no studies taking account of the response to AEDs of the ID populations based on the WHO Diagnostic and Statistical Manual of Mental Disorders criteria of clinical severity of ID were identified.There is a significant shortfall in suitably powered studies to provide sufficient evidence for safe prescribing of AEDs to people with ID.Keywords
Funding Information
- Eisai
- GlaxoSmithKline
- Pfizer
This publication has 22 references indexed in Scilit:
- Epilepsy and intellectual disability: Does epilepsy increase the likelihood of co-morbid psychopathology?Research in Developmental Disabilities, 2011
- Rufinamide for the treatment of Lennox–Gastaut syndromeExpert Opinion on Pharmacotherapy, 2011
- Rufinamide for generalized seizures associated with Lennox–Gastaut syndromeNeurology, 2008
- Co-morbidity of psychiatric disorder and medical illness in people with intellectual disabilitiesCurrent Opinion in Psychiatry, 2007
- The SANAD study of effectiveness of valproate, lamotrigine, or topiramate for generalised and unclassifiable epilepsy: an unblinded randomised controlled trialThe Lancet, 2007
- Adult epilepsyThe Lancet, 2006
- The effects of antiepileptic medications on the social skills of individuals with mental retardationResearch in Developmental Disabilities, 2004
- Psychopathology in people with epilepsy and intellectual disability; an investigation of potential explanatory variablesJournal of Neurology, Neurosurgery & Psychiatry, 2003
- A randomized open-label study of gabapentin and lamotrigine in adults with learning disability and resistant epilepsySeizure, 2001
- Clobazam in the Treatment of Epilepsy: A Review of the LiteratureEpilepsia, 1994